VACUNAS CON VESíCULAS DE MEMBRANA EXTERNA: ¿EL FUTURO DE LAS VACUNAS? DOI Creative Commons
Pablo Díaz-Hernández

Deleted Journal, Journal Year: 2023, Volume and Issue: 27, P. 125 - 137

Published: Jan. 1, 2023

Preventing the spread of disease, whether by viral or bacterial pathogens, involves protectingbillions people and subsequent factors in process. Vaccination is undoubtedly mosteffective way to achieve this. Many countries prioritize vaccination campaigns for publichealth well-being their inhabitants. Vaccine development has been based on 4 main types,whose response effective many diseases; however, some them have shown havelimitations certain clinical conditions. Therefore, identification new candidates forvaccine attracted attention research groups. According thehumoral cellular immune induced a vaccine, its effectiveness against diseaseis measured. Microvesicles (MVs) are nanometer-sized vesicles that secreted into extracellularspace, whose contents consist carbohydrates, proteins, lipids, nucleic acids (DNAand RNA) other metabolites. This conformation can be used as vehicle transport antigensand immunogenic molecules directly target cells. A vaccine multidrug-resistantbacterium Neisseria gonorrhoeae already developed using outer membrane vesicles(OMVs), was promising. In this review, we will study participation ofmicrovesicles Gram-positive Gram-negative bacteria different isolates, thepathogenicity processes which they participate, usefulness immunogenicmolecules components multidrug-resistantbacteria.

Language: Английский

Outer Membrane Vesicles (OMVs) as Biomedical Tools and Their Relevance as Immune-Modulating Agents against H. pylori Infections: Current Status and Future Prospects DOI Open Access
Abeer Ahmed Qaed Ahmed, Roberta Besio, Lin Xiao

et al.

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(10), P. 8542 - 8542

Published: May 10, 2023

Outer membrane vesicles (OMVs) are lipid-membrane-bounded nanoparticles that released from Gram-negative bacteria via vesiculation of the outer membrane. They have vital roles in different biological processes and recently, they received increasing attention as possible candidates for a broad variety biomedical applications. In particular, OMVs several characteristics enable them to be promising immune modulation against pathogens, such their ability induce host responses given resemblance parental bacterial cell. Helicobacter pylori (H. pylori) is common bacterium infects half world's population causes gastrointestinal diseases peptic ulcer, gastritis, gastric lymphoma, carcinoma. The current H. treatment/prevention regimens poorly effective limited success. This review explores status future prospects biomedicine with special focus on use potential candidate its associated diseases. emerging strategies can used design viable immunogenic discussed.

Language: Английский

Citations

24

Bacterial Membrane Vesicles as Smart Drug Delivery and Carrier Systems: A New Nanosystems Tool for Current Anticancer and Antimicrobial Therapy DOI Creative Commons
Pınar Aytar Çelik, Kubra Erdogan-Gover, Dilan Barut

et al.

Pharmaceutics, Journal Year: 2023, Volume and Issue: 15(4), P. 1052 - 1052

Published: March 24, 2023

Bacterial membrane vesicles (BMVs) are known to be critical communication tools in several pathophysiological processes between bacteria and host cells. Given this situation, BMVs for transporting delivering exogenous therapeutic cargoes have been inspiring as promising platforms developing smart drug delivery systems (SDDSs). In the first section of review paper, starting with an introduction pharmaceutical technology nanotechnology, we delve into design classification SDDSs. We discuss characteristics including their size, shape, charge, effective production purification techniques, different methods used cargo loading encapsulation. also shed light on release mechanism, carriers, recent remarkable findings potential anticancer antimicrobial therapy. Furthermore, covers safety challenges that need overcome clinical use. Finally, advancements prospects SDDSs highlight revolutionizing fields nanomedicine delivery. conclusion, paper aims provide a comprehensive overview state-of-the-art field SDDSs, encompassing design, composition, fabrication, purification, characterization, well various strategies targeted Considering information, aim is researchers understanding current state enabling them identify gaps formulate new hypotheses accelerate progress field.

Language: Английский

Citations

19

Saliva biofilm-derived outer membrane vesicles regulate biofilm formation and immune response of oral epithelial cells on titanium surfaces DOI
Baoxin Huang, Chun Liu, Jieting Yang

et al.

Clinical Oral Investigations, Journal Year: 2024, Volume and Issue: 28(1)

Published: Jan. 4, 2024

Language: Английский

Citations

5

Brain-tumor-seeking and serpin-inhibiting outer membrane vesicles restore plasmin-mediated attacks against brain metastases DOI

Mengyuan Zhou,

Yuanyuan Lin, Haiyan Chen

et al.

Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 375, P. 116 - 126

Published: Sept. 6, 2024

Language: Английский

Citations

4

Innovative design of bacterial outer membrane vesicles for vaccine development DOI

Qinzhen Cheng,

Gaoli Niu,

Yiling He

et al.

Nano Today, Journal Year: 2025, Volume and Issue: 61, P. 102650 - 102650

Published: Feb. 1, 2025

Language: Английский

Citations

0

Outer Membrane Vesicles (OMVs) as Antibiotic Carriers: A Promising Approach DOI Creative Commons
Gülgün Bosgelmez Tinaz

Pharmedicine journal., Journal Year: 2025, Volume and Issue: 2(1), P. 1 - 7

Published: Feb. 28, 2025

The misuse and overuse of antibiotics have driven the emergence antibiotic-resistant bacteria in recent decades. With increasing incidence resistant strains significant slowdown new antibiotic discoveries, treating bacterial infections has become more challenging. Therefore, there is an urgent need to explore alternative treatments, such as using outer membrane vesicles (OMVs) for targeted delivery. OMVs are nanoscale, spherical structures originating from Gram-negative bacteria's membrane. These naturally released by almost all types into their environment during growth play crucial roles pathogenesis transporting specific biomolecules, toxins other virulence factors, host cells. Due unique ability encapsulate transport various bioactive molecules across Gram negative cell membrane, nanosized hold potential a novel platform This review discusses biogenesis, biofunctions, antibacterial applications OMVs.

Language: Английский

Citations

0

The mechanism of outer membrane vesicle-mediated resistance to carbapenem antibiotics DOI
Dan Zhou, Xiaoyu Yang,

Yu‐Hong Gao

et al.

Microbial Pathogenesis, Journal Year: 2025, Volume and Issue: 205, P. 107654 - 107654

Published: April 30, 2025

Language: Английский

Citations

0

Separation and Characterization of Heterogeneity Among Various Sizes of Outer Membrane Vesicles Derived from the Probiotic Escherichia coli Nissle 1917 DOI Creative Commons

Ning Li,

Hong‐Bo Xin, Ke‐Yu Deng

et al.

Membranes, Journal Year: 2025, Volume and Issue: 15(5), P. 141 - 141

Published: May 5, 2025

Outer membrane vesicles (OMVs) are extracellular secreted by Gram-negative bacteria with diameters of 20–250 nm. OMVs contain various biologically active substances from their parent bacteria, such as proteins, lipids, and nucleic acids. Escherichia coli Nissle 1917 (EcN) is a probiotic that resides in the human intestine. EcN-derived pivotal modulating intestinal immune responses. However, few studies have addressed heterogeneity terms size, significantly limiting research on clinical applications. Currently, there lack feasible methods for obtaining different sizes. To address this knowledge gap, we developed filtration method to isolate varying In study, first used gradient high-purity conducted proteomic analysis. Subsequently, separate size. We successfully obtained three specific sizes: <50 nm, 50–100 100–300 then performed analyses these compared protein profiles. Finally, ability each OMV type induce RAW264.7 macrophages secrete pro-inflammatory factor interleukin (IL)-1β anti-inflammatory IL-10. The contained 646 proteins overall; those sizes types. Among them, nm group fewer (262 types total) than (1603 types) (1568 groups. Furthermore, had (40) (215) (209) also found concentrations IL-1β IL-10 following co-incubation showed stronger effect inducing inflammatory cytokine secretion other two This study provides direct experimental evidence exhibit heterogeneous properties.

Language: Английский

Citations

0

Opportunities for engineering outer membrane vesicles using synthetic biology approaches DOI Open Access
Richard Kelwick, Alexander J. Webb, Paul S. Freemont

et al.

Extracellular Vesicles and Circulating Nucleic Acids, Journal Year: 2023, Volume and Issue: 4(2), P. 255 - 61

Published: Jan. 1, 2023

Gram-negative bacteria naturally shed lipid vesicles, which contain complex molecular cargoes, from their outer membrane. These membrane vesicles (OMVs) have important biological functions relating to microbial stress responses, microbiome regulation, and host-pathogen interactions. OMVs are also attractive vehicles for delivering drugs, vaccines, other therapeutic agents because of ability interact with host cells natural immunogenic properties. set a positive impact on biotechnological medical applications including diagnostics, bioremediation, metabolic engineering. We envision that the field synthetic biology offers compelling opportunity further expand accelerate foundational research downstream in range provision OMV-based healthcare technologies. In our opinion, we discuss how current potential future synergies between OMV approaches might help real-world benefit animal human health.

Language: Английский

Citations

8

Bacterial outer membrane vesicles as drug delivery carrier for photodynamic anticancer therapy DOI Creative Commons
Yuan Jiang,

Zunzhen Zhou,

Chongzhi Liu

et al.

Frontiers in Chemistry, Journal Year: 2023, Volume and Issue: 11

Published: Oct. 17, 2023

Photodynamic Therapy (PDT) is an effective tumor treatment strategy that not only induces photocytotoxicity to kill cells directly but also activates the immune system in body generate tumor-specific immunity, preventing cancer metastasis and recurrence. However, some limitations of PDT limit therapeutic efficacy deep tumors. Previous studies have used different types nanoparticles (NPs) as drug carriers photosensitizers (PSs) overcome shortcomings improve efficacy. Among them, bacterial outer membrane vesicles (OMVs) natural advantages for PS delivery. In addition targeted delivery PSs into cells, their unique immunogenicity helps them serve adjuvants enhance PDT-induced effect, providing new ideas photodynamic anticancer therapy. Therefore, this review, we will introduce biogenesis functions OMVs research on PDT. Finally, discuss challenges prospects a versatile carrier

Language: Английский

Citations

7